Content below copied verbatim from another website. If you are suffering from permanent Finasteride side effects, please participate in this initiative.
----------
March 17, 2010 - posted by:
Michael S. Irwig M.D., F.A.C.E.
Assistant Professor of Medicine,
George Washington University School of Medicine
Division of Endocrinology, Medical Faculty Associates
Director, Center for Andrology
-------
We now have official approval from GW University to begin the study.
Dr. Irwig and colleagues at the George Washington University are conducting a study to describe possible persistent sexual side effects related to the use of finasteride (Propecia).
Interested subjects would email and complete a study consent form and 5 item questionnaire. A telephone interview of less than 30 minutes would be scheduled so that Dr. Irwig can ask basic questions about the subject’s medical, psychiatric and sexual histories.
All information will be kept confidential and each subject will be assigned a unique ID number so that the data is analyzed anonymously. Participation is entirely voluntary.
-------
Eligible subjects are:
1) Men who between the ages of 18 and 40 took finasteride (Propecia or Proscar) for male pattern hair loss treatment or prevention
2) Men who experienced new sexual dysfunction (low libido, erectile dysfunction, decreased orgasm) that has persisted despite stopping finasteride (Propecia)
Subjects are not eligible if they had:
1) Any significant baseline sexual dysfunction before using finasteride.
2) Psychiatric diagnoses including depression, anxiety, schizophrenia, etc.
3) Medication use other than finasteride BEFORE or DURING treatment with finasteride.
--------
We invite you to be a part of this important project so that we can report the persistent sexual side effects of finasteride to both the medical community (doctors who prescribe the medicine) and to the general population.
Interested subjects should send their signed consent forms (scanned to PDF, JPG image) to propeciastudy@gmail.com to participate.
Alternatively, you may also FAX or MAIL your signed consent form:
FAX: 202-741-2490
MAIL: Dr. Irwig
2150 Pennsylvania Ave Norwood # ACC 3-416
Washington DC 20037
----------
March 17, 2010 - posted by:
Michael S. Irwig M.D., F.A.C.E.
Assistant Professor of Medicine,
George Washington University School of Medicine
Division of Endocrinology, Medical Faculty Associates
Director, Center for Andrology
-------
We now have official approval from GW University to begin the study.
Dr. Irwig and colleagues at the George Washington University are conducting a study to describe possible persistent sexual side effects related to the use of finasteride (Propecia).
Interested subjects would email and complete a study consent form and 5 item questionnaire. A telephone interview of less than 30 minutes would be scheduled so that Dr. Irwig can ask basic questions about the subject’s medical, psychiatric and sexual histories.
All information will be kept confidential and each subject will be assigned a unique ID number so that the data is analyzed anonymously. Participation is entirely voluntary.
-------
Eligible subjects are:
1) Men who between the ages of 18 and 40 took finasteride (Propecia or Proscar) for male pattern hair loss treatment or prevention
2) Men who experienced new sexual dysfunction (low libido, erectile dysfunction, decreased orgasm) that has persisted despite stopping finasteride (Propecia)
Subjects are not eligible if they had:
1) Any significant baseline sexual dysfunction before using finasteride.
2) Psychiatric diagnoses including depression, anxiety, schizophrenia, etc.
3) Medication use other than finasteride BEFORE or DURING treatment with finasteride.
--------
We invite you to be a part of this important project so that we can report the persistent sexual side effects of finasteride to both the medical community (doctors who prescribe the medicine) and to the general population.
Interested subjects should send their signed consent forms (scanned to PDF, JPG image) to propeciastudy@gmail.com to participate.
Alternatively, you may also FAX or MAIL your signed consent form:
FAX: 202-741-2490
MAIL: Dr. Irwig
2150 Pennsylvania Ave Norwood # ACC 3-416
Washington DC 20037